A census of human cancer genes

The Pfam Protein Families Database

Bateman, A. G. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.276 · Cited by 14,075

PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785

Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors

Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,487

The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer

Fishel, R. A., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J. E., Kane, M., & Kolodner, R. D. (1993) · Cell · doi:10.1016/0092-8674(93)90546-3 · Cited by 2,884

A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase

Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785

A cell cycle regulator potentially involved in genesis of many tumor types

Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751

PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors

Heinrich, M. C., Corless, C. L., Duensing, A. U., McGreevey, L. S., Chen, C.-J., Joseph, N. E., Singer, S., Griffith, D., Haley, A., Town, A., et al. (2003) · Science · doi:10.1126/science.1079666 · Cited by 2,297

Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer

Leach, F. S., Nicolaides, N. C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R. E., Peltomäki, P., Sistonen, P., Aaltonen, L. A., Nyström, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90330-s · Cited by 2,271

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E. W., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,992

A serine/threonine kinase gene defective in Peutz–Jeghers syndrome

Hemminki, A., Markie, D., Tomlinson, I. P. M., Avizienyte, E., Roth, S., Loukola, A., Bignell, G. R., Warren, W., Aminoff, M., Höglund, P., et al. (1998) · Nature · doi:10.1038/34432 · Cited by 1,680

An integrated approach to identify causal network modules of complex diseases with application to colorectal cancer

Wen, Z., Liu, Z.-P., Liu, Z., Zhang, Y., & Chen, L. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2012-001168 · Cited by 64

Predicting cancer type from tumour DNA signatures

Soh, K. P., Szczurek, E., Sakoparnig, T., & Beerenwinkel, N. (2017) · Genome Medicine · doi:10.1186/s13073-017-0493-2 · Cited by 65

Somatic Mutations of ErbB4

Tvorogov, D., Sundvall, M., Kurppa, K. J., Hollmén, M., Repo, S., Johnson, M. S., & Elenius, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805438200 · Cited by 64

Manifestation, mechanisms and mysteries of gene amplifications

Myllykangas, S., & Knuutila, S. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.07.045 · Cited by 64

Perspectives for the use of structural information and chemical genetics to develop inhibitors of Janus kinases

Haan, C., Behrmann, I., & Haan, S. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01018.x · Cited by 64

Genetically modified pigs to model human diseases

Flisikowska, T., Kind, A., & Schnieke, A. (2013) · Journal of Applied Genetics · doi:10.1007/s13353-013-0182-9 · Cited by 63

Mutational profiling of kinases in glioblastoma

Bleeker, F. E., Lamba, S., Zanon, C., Molenaar, R. J., Hulsebos, T. J. M., Troost, D., van Tilborg, A. A., Vandertop, W. P., Leenstra, S., Noorden, C. J. F. V., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-718 · Cited by 67

BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations

Holstege, H. H., Horlings, H. M., Velds, A., Langerød, A., Børresen‐Dale, A., van de Vijver, M. J., Nederlof, P. M., & Jonkers, J. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-654 · Cited by 63

Cell cycle-related kinase mediates viral-host signalling to promote hepatitis B virus-associated hepatocarcinogenesis

Yu, Z., Gao, Y., Feng, H., Lee, Y.-Y., Li, M. S. M., Tian, Y., Go, M. Y. Y., Yu, D., Cheung, Y. S., Lai, P. B. S., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305584 · Cited by 63

Prediction of Human Disease-Related Gene Clusters by Clustering Analysis

Sun, P. G., Gao, L., & Han, S. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.61 · Cited by 63

Genetic modifiers of the BRD4-NUT dependency of NUT midline carcinoma uncovers a synergism between BETis and CDK4/6isPreprint

Liao, S., Maertens, O., Cichowski, K. M., & Elledge, S. J. (2018) · Genes & Development · doi:10.1101/gad.315648.118 · Cited by 64

NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes

An, Ö., Pendino, V., D’Antonio, M., Ratti, E., Gentilini, M., & Ciccarelli, F. D. (2014) · Database · doi:10.1093/database/bau015 · Cited by 63

The gene regulatory network for breast cancer: integrated regulatory landscape of cancer hallmarks

Emmert‐Streib, F., Simoes, R. D. M., Mullan, P. B., Haibe‐Kains, B., & Dehmer, M. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00015 · Cited by 63

RAS Transformation Requires CUX1-Dependent Repair of Oxidative DNA Damage

Ramdzan, Z. M., Vadnais, C., Pal, R., Vandal, G., Cadieux, C., Leduy, L., Davoudi, S., Hulea, L., Yao, L., Karnezis, A. N., et al. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001807 · Cited by 66

Multiscale Integration of -Omic, Imaging, and Clinical Data in Biomedical Informatics

Phan, J. H., Quo, C. F., Cheng, C., & Wang, M. D. (2012) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2012.2212427 · Cited by 62

Using single cell sequencing data to model the evolutionary history of a tumor

Kim, K. I., & Simon, R. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-27 · Cited by 63

An analysis of substitution, deletion and insertion mutations in cancer genes

Iengar, P. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks290 · Cited by 62

Systematical analysis of lncRNA–mRNA competing endogenous RNA network in breast cancer subtypes

Zhou, S., Wang, L., Yang, Q., Liu, H., Meng, Q., Jiang, L., Wang, S., & Jiang, W. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4678-1 · Cited by 62

Mutation–selection balance and compensatory mechanisms in tumour evolution

Persi, E., Wolf, Y. I., Horn, D., Ruppin, E., Demichelis, F., Gatenby, R. A., Gillies, R. J., & Koonin, E. V. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-020-00299-4 · Cited by 64

Detecting Disease-Specific Dysregulated Pathways Via Analysis of Clinical Expression Profiles

Ulitsky, I., Karp, R. M., & Ron Shamir, A. (2008) · Lecture notes in computer science · doi:10.1007/978-3-540-78839-3_30 · Cited by 61

The proteomic signature of NPM/ALK reveals deregulation of multiple cellular pathways

Lim, M. S., Carlson, M. L., Crockett, D. K., Fillmore, G. C., Abbott, D. R., Elenitoba-Johnson, O. F., Tripp, S. R., Rassidakis, G. Z., Medeiros, L. J., Szankasi, P., et al. (2009) · Blood · doi:10.1182/blood-2009-02-204735 · Cited by 61

Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration

Borczuk, A., Pei, J., Taub, R. N., Levy, B., Nahum, O., Chen, J., Chen, K., & Testa, J. R. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1145850 · Cited by 61

Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences

Waanders, E., Scheijen, B., Jongmans, M. C. J., Venselaar, H., van Reijmersdal, S. V., van Dijk, A. H. A., Pastorczak, A. K., Weren, R. D. A., van der Schoot, C. E., van de Vorst, M., et al. (2016) · Leukemia · doi:10.1038/leu.2016.277 · Cited by 61

Identifying mutual exclusivity across cancer genomes: computational approaches to discover genetic interaction and reveal tumor vulnerability

Deng, Y., Luo, S., Deng, C., Luo, T., Yin, W., Zhang, H., Zhang, Y., Zhang, X., Lan, Y., Ping, Y., et al. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx109 · Cited by 65

Kras mutant genetically engineered mouse models of human cancers are genomically heterogeneous

Chung, W., Daemen, A., Cheng, J. H., Long, J. E., Cooper, J. E., Wang, B.-E., Tran, C., Singh, M., Gnad, F., Modrusan, Z. D., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708391114 · Cited by 61

Different mutation profiles between epithelium and stroma in endometriosis and normal endometrium

Suda, K., Nakaoka, H., Yoshihara, K., Ishiguro, T., Adachi, S., Kase, H., Motoyama, T., Inoue, I., & Enomoto, T. (2019) · Human Reproduction · doi:10.1093/humrep/dez155 · Cited by 61

Germline Features Associated with Immune Infiltration in Solid Tumors

Shahamatdar, S., He, M. X., Reyna, M. A., Gusev, A., AlDubayan, S. H., Allen, E. M. V., & Ramachandran, S. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.039 · Cited by 61

Small Molecule Kinase Inhibitors as Anti-Cancer Therapeutics

Chahrour, O., Cairns, D., & Omran, Z. (2012) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955712800493915 · Cited by 60

ChiTaRS: a database of human, mouse and fruit fly chimeric transcripts and RNA-sequencing data

Frenkel‐Morgenstern, M., Gorohovski, A., Lacroix, V., Rogers, M. F., Ibáñez, K., Boullosa, C., Andrés‐León, E., Ben‐Hur, A., & Valencia, A. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1041 · Cited by 60

Detection of Somatic Mutations by High-Resolution DNA Melting (HRM) Analysis in Multiple Cancers

Bosquet, J. G., Calcei, J. G., Wei, J. S., García‐Closas, M., Sherman, M. E., Hewitt, S. M., Vockley, J. G., Lissowska, J., Yang, H., Khan, J. I., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014522 · Cited by 60

Systematic dissection of dysregulated transcription factor–miRNA feed-forward loops across tumor types

Jiang, W., Mitra, R., Lin, C.-C., Wang, Q., Cheng, F., & Zhao, Z. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbv107 · Cited by 60

Lobular Carcinomas In Situ Display Intralesion Genetic Heterogeneity and Clonal Evolution in the Progression to Invasive Lobular Carcinoma

Lee, J. Y., Schizas, M., Geyer, F. C., Selenica, P., Piscuoglio, S., Sakr, R. A., Ng, C. K. Y., Carniello, J. V. S., Towers, R., Giri, D. D., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1103 · Cited by 60

A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors

Menon, M. R., Elliott, R. J. R., Bowers, L., Balan, N., Rafiq, R., Costa-Cabral, S., Munkonge, F. M., Trinidade, I., Porter, R. A., Campbell, A. D., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-36447-4 · Cited by 60

Aberrant splicing in B-cell acute lymphoblastic leukemia

Black, K. L., Naqvi, A. S., Asnani, M., Hayer, K. E., Yang, S. Y., Gillespie, E. B., Bagashev, A., Pillai, V., Tasian, S. K., Gazzara, M. R., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky946 · Cited by 61

Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma

Depreeuw, J., Stelloo, E., Osse, E. M., Creutzberg, C. L., Nout, R. A., Moisse, M., Garcia-Dios, D. A., Dewaele, M., Willekens, K., Marine, J., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0566 · Cited by 59

The therapeutic effects of Ficus carica extract as antioxidant and anticancer agent

Abdel-Rahman, R., Ghoneimy, E. A., Abdelwahab, A. E., El‐Deeb, N. M., Salem, M. S., Salama, E., & Ahmed, T. A.-F. (2021) · South African Journal of Botany · doi:10.1016/j.sajb.2021.04.019 · Cited by 59

The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets

Knol, J. C., Lyu, M., Böttger, F., Monteiro, M. N., Pham, T. V., Rolfs, F., Vallés‐Martí, A., Schelfhorst, T., Haas, R. R. D. G., Bijnsdorp, I. V., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.05.003 · Cited by 65

Dysregulated transcription across diverse cancer types reveals the importance of RNA-binding protein in carcinogenesis

Wang, J., Liu, Q., & Shyr, Y. (2015) · BMC Genomics · doi:10.1186/1471-2164-16-s7-s5 · Cited by 61

Identifying potential cancer driver genes by genomic data integration

Chen, Y., Hao, J., Jiang, W., He, T., Zhang, X., Jiang, T., & Jiang, R. (2013) · Scientific Reports · doi:10.1038/srep03538 · Cited by 59

Genomic Instability and Prognosis in Breast Carcinomas

Kronenwett, U., Ploner, A., Zetterberg, A., Bergh, J. C. S., Hall, P., Auer, G., & Yudi Pawitan, Y. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0080 · Cited by 59

The Functional Landscape of Hsp27 Reveals New Cellular Processes such as DNA Repair and Alternative Splicing and Proposes Novel Anticancer Targets

Katsogiannou, M., Andrieu, C., Baylot, V., Baudot, A., Dusetti, N., Gayet, O., Finetti, P., Garrido, C., Birnbaum, D., Bertucci, F., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.041228 · Cited by 59

Histotype-specific copy-number alterations in ovarian cancer

Huang, R. Y., Chen, G. B., Matsumura, N., Lai, H., Mori, S., Li, J., Wong, M. K., Konishi, I., Thiery, J. P., & Goh, L. K. (2012) · BMC Medical Genomics · doi:10.1186/1755-8794-5-47 · Cited by 59

Defining the blueprint of the cancer genome

Velculescu, V. E. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn096 · Cited by 59

Potent Dual BET Bromodomain-Kinase Inhibitors as Value-Added Multitargeted Chemical Probes and Cancer Therapeutics

Ember, S. W., Lambert, Q. T., Berndt, N., Gunawan, S., Ayaz, M., Tauro, M., Zhu, J., Cranfill, P. J., Greninger, P., Lynch, C. C., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0568-t · Cited by 60

ATR Is a Therapeutic Target in Synovial Sarcoma

Jones, S. E., Fleuren, E. D. G., Frankum, J. R., Konde, A., Williamson, C. T., Krastev, D. B., Pemberton, H. N., Campbell, J., Gulati, A., Elliott, R. J. R., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-2056 · Cited by 61

Gene expression profiling in colon of mice exposed to food additive titanium dioxide (E171)

Proquin, H., Jetten, M. J. A., Jonkhout, M. C. M., Garduño-Balderas, L. G., Briedé, J. J., de Kok, T. M. C. M., Chirino, Y. I., & Loveren, H. V. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.11.011 · Cited by 59

Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesis

Kodama, T., Yi, J., Newberg, J. Y., Tien, J. C.-Y., Wu, H., Finegold, M. J., Kodama, M., Wei, Z., Tamura, T., Takehara, T., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808968115 · Cited by 61

The methyl-CpG-binding protein MECP2 is required for prostate cancer cell growth

Bernard, D., Gil, J., Dumont, P., Rizzo, S., Monté, D., Quatannens, B., Hudson, D. L., Visakorpi, T., Fuks, F., & de Launoit, Y. (2005) · Oncogene · doi:10.1038/sj.onc.1209179 · Cited by 59

Identification of Nidogen 1 as a lung metastasis protein through secretome analysisPreprint

Alečković, M., Wei, Y., LeRoy, G., Sidoli, S., Liu, D. D., Garcia, B. A., & Kang, Y. (2017) · Genes & Development · doi:10.1101/gad.301937.117 · Cited by 60

Order Matters: The Order of Somatic Mutations Influences Cancer EvolutionPreprint

Kent, D. G., & Green, A. R. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027060 · Cited by 61

Targeting the Translesion Synthesis Pathway for the Development of Anti-Cancer Chemotherapeutics

Korzhnev, D. M., & Hadden, M. K. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00596 · Cited by 58

Comparative analysis of methods for identifying somatic copy number alterations from deep sequencing data

Alkodsi, A., Louhimo, R., & Hautaniemi, S. (2014) · Briefings in Bioinformatics · doi:10.1093/bib/bbu004 · Cited by 58

Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncology

Workman, P., Al‐Lazikani, B., & Clarke, P. A. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.06.004 · Cited by 60

Cyclooxygenase- and lipoxygenase-mediated DNA damage

Speed, N., & Blair, I. A. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9298-8 · Cited by 58

Genotype, phenotype and cancer: Role of low penetrance genes and environment in tumour susceptibility

Kotnis, A. L., Sarin, R., & Mulherkar, R. (2005) · Journal of Biosciences · doi:10.1007/bf02705154 · Cited by 58

Functional Characterization of Human Cancer-Derived TRKB Mutations

Geiger, T. R., Song, J., Rosado, A., & Peeper, D. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016871 · Cited by 58

OncodriveROLE classifies cancer driver genes in loss of function and activating mode of action

Schroeder, M. P., Rubio-Pérez, C., Tamborero, D., González-Pérez, A., & López-Bigas, N. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu467 · Cited by 58

MSEA: detection and quantification of mutation hotspots through mutation set enrichment analysis

Jia, P., Wang, Q., Chen, Q., Hutchinson, K. E., Pao, W. J., & Zhao, Z. (2014) · Genome biology · doi:10.1186/preaccept-1822061407140231 · Cited by 58

Statistically identifying tumor suppressors and oncogenes from pan-cancer genome-sequencing data

Kumar, R. D., Searleman, A. C., Swamidass, S. J., Griffith, O. L., & Bose, R. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv430 · Cited by 58

Transposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression

Rangel, R., Lee, S.-C., Ban, K. H.-K., Guzman‐Rojas, L., Mann, M. B., Newberg, J. Y., Kodama, T., McNoe, L. A., Selvanesan, L., Ward, J. M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613859113 · Cited by 58

Integrative analysis of genome-wide gene copy number changes and gene expression in non-small cell lung cancer

Jabs, V., Edlund, K., König, H., Grinberg, M., Madjar, K., Rahnenführer, J., Ekman, S., Bergkvist, M., Holmberg, L., Ickstadt, K., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187246 · Cited by 58

Mutational signatures and chromosome alteration profiles of squamous cell carcinomas of the vulva

Han, M.-R., Shin, S. Y., Park, H., Kim, M. S., Lee, S. H., Song, S. Y., Song, S. Y., Lee, S. H., & Chung, Y. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.265 · Cited by 58

Combined burden and functional impact tests for cancer driver discovery using DriverPower

Shuai, S., PCAWG Drivers and Functional Interpretation Working Group, Abascal, F., Amin, S. B., Bader, G. D., Bandopadhayay, P., Barenboim, J., Beroukhim, R., Bertl, J., Boroevich, K. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13929-1 · Cited by 60

Mechanisms of oncogenic cooperation in cancer initiation and metastasis.

Pedraza, L. G. (2006) · PubMed Central · Cited by 58

Comment on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers"

Forrest, W. F., & Cavet, G. (2007) · Science · doi:10.1126/science.1138179 · Cited by 58

Mutational signatures and mutable motifs in cancer genomes

Rogozin, I. B., Pavlov, Y. I., Goncearenco, A., De, S., Lada, A. G., Poliakov, E., Panchenko, A. R., & Cooper, D. N. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx049 · Cited by 58

Integrative approach for prioritizing cancer genes in sporadic colon cancer

Reid, J. F., Gariboldi, M., Sokolova, V., Capobianco, P., Lampis, A., Perrone, F., Signoroni, S., Costa, A., Leo, E., Pilotti, S., et al. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20697 · Cited by 57

The genomic profile of parathyroid carcinoma based on whole‐genome sequencing

Hu, Y., Zhang, X., Wang, O., Bi, Y., Xing, X., Cui, M., Wang, M., Tao, W., Liao, Q., & Zhao, Y. (2020) · International Journal of Cancer · doi:10.1002/ijc.33166 · Cited by 57

The Next Frontier: Translational Development of Ubiquitination, SUMOylation, and NEDDylation in Cancer

Pellegrino, N., Güven, A., Gray, K., Shah, P., Kasture, G., Nastke, M.-D., Thakurta, A., Gesta, S., Vishnudas, V. K., Narain, N. R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073480 · Cited by 58

The Cap-Dependent Translation Apparatus Integrates and Amplifies Cancer Pathways

Polunovsky, V. A., & Bitterman, P. B. (2006) · RNA Biology · doi:10.4161/rna.3.1.2718 · Cited by 57

Genomic Aberrations and Cellular Heterogeneity in SV40-Immortalized Human Corneal Epithelial Cells

Yamasaki, K., Kawasaki, S., Young, R. D., Fukuoka, H., Tanioka, H., Nakatsukasa, M., Quantock, A. J., & Kinoshita, S. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2239 · Cited by 59

Integration of Random Forest Classifiers and Deep Convolutional Neural Networks for Classification and Biomolecular Modeling of Cancer Driver Mutations

Agajanian, S., Odeyemi, O., & Verkhivker, G. M. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00044 · Cited by 57

Dynamics of biological systems: role of systems biology in medical research

Assmus, H. E., Herwig, R., Cho, K., & Wolkenhauer, O. (2006) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.6.6.891 · Cited by 60

X-CNV: genome-wide prediction of the pathogenicity of copy number variations

Zhang, L., Shi, J., Ouyang, J., Zhang, R., Tao, Y., Yuan, D., Lv, C., Wang, R., Ning, B., Roberts, R. A., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00945-4 · Cited by 59

ProKinO: A Unified Resource for Mining the Cancer Kinome

McSkimming, D. I., Dastgheib, S., Talevich, E., Narayanan, A., Katiyar, S., Taylor, S. S., Kochut, K. J., & Kannan, N. (2014) · Human Mutation · doi:10.1002/humu.22726 · Cited by 56

Phosphoproteomics and cancer research

Ashman, K., & Villar, E. L. (2009) · Clinical & Translational Oncology · doi:10.1007/s12094-009-0369-z · Cited by 56

Potential role of LMP2 as tumor-suppressor defines new targets for uterine leiomyosarcoma therapy

Hayashi, T., Horiuchi, A., Sano, K., Hiraoka, N., Kasai, M., Ichimura, T., Sudo, T., Tagawa, Y., Nishimura, R., Ishiko, O., et al. (2011) · Scientific Reports · doi:10.1038/srep00180 · Cited by 56

Metabolic control analysis to identify optimal drug targets

Hornberg, J. J., Bruggeman, F. J., Bakker, B. M., & Westerhoff, H. V. (2007) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7567-6_7 · Cited by 58

IPAD: the Integrated Pathway Analysis Database for Systematic Enrichment Analysis

Zhang, F., & Drabier, R. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-s15-s7 · Cited by 56

Pigs as models of human cancers

Flisikowska, T., Kind, A., & Schnieke, A. (2016) · Theriogenology · doi:10.1016/j.theriogenology.2016.04.058 · Cited by 56

Whole-Exome Sequencing Reveals Frequent Mutations in Chromatin Remodeling Genes in Mammary and Extramammary Paget’s Diseases

Zhang, G., Zhou, S., Zhong, W., Hong, L., Wang, Y., Lu, S., Pan, J., Huang, Y., Su, M., Crawford, R. I., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.08.030 · Cited by 56

Conventionally used reference genes are not outstanding for normalization of gene expression in human cancer research

Jo, J., Choi, S., Oh, J., Lee, S., Choi, S. Y., Kim, K. K., & Park, C. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2809-2 · Cited by 58

LOTUS: A single- and multitask machine learning algorithm for the prediction of cancer driver genes

Collier, O., Stoven, V., & Vert, J. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007381 · Cited by 56

The Evolution of Human Cancer Gene Duplications across Mammals

Tollis, M., Schneider‐Utaka, A. K., & Maley, C. C. (2020) · Molecular Biology and Evolution · doi:10.1093/molbev/msaa125 · Cited by 56

Identification of relevant genetic alterations in cancer using topological data analysis

Rabadán, R., Mohamedi, Y., Rubin, U., Chu, T., Alghalith, A. N., Elliott, O., Arnes, L., Cal, S., Obaya, Á. J., Levine, A. J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17659-7 · Cited by 56

Genome and proteome annotation: organization, interpretation and integration

Reeves, G. A., Talavera, D., & Thornton, J. M. (2008) · Journal of The Royal Society Interface · doi:10.1098/rsif.2008.0341 · Cited by 60

Statistical behavior of complex cancer karyotypes

Höglund, M., Frigyesi, A., Säll, T., Gisselsson, D., & Mitelman, F. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20143 · Cited by 56

From cytogenetics to next-generation sequencing technologies: advances in the detection of genome rearrangements in tumorsThis paper is one of a selection of papers published in this Special Issue, entitled CSBMCB — Systems and Chemical Biology, and has undergone the Journal's usual peer review process.

Morozova, O., & Marra, M. A. (2008) · Biochemistry and Cell Biology · doi:10.1139/o08-003 · Cited by 46

Drugging cancer genomes

Workman, P., & Al‐Lazikani, B. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4184 · Cited by 55

Mechanism of DNA resection during intrachromosomal recombination and immunoglobulin class switching

Bothmer, A., Rommel, P. C., Gazumyan, A., Polato, F., Reczek, C. R., Muellenbeck, M. F., Schaetzlein, S., Edelmann, W., Chen, P., Brosh, R. M., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20121975 · Cited by 62

Deep learning for cancer type classification and driver gene identification

Zeng, Z., Mao, C., Vo, A. H., Li, X., Nugent, J. O., Khan, S. A., Clare, S. E., & Luo, Y. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04400-4 · Cited by 57

In vivo selection of hematopoietic progenitor cells and temozolomide dose intensification in rhesus macaques through lentiviral transduction with a drug resistance gene

Larochelle, A., Choi, U., Shou, Y., Naumann, N., Loktionova, N. A., Clevenger, J. R., Krouse, A. E., Metzger, M. E., Donahue, R. E., Kang, E. M., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37506 · Cited by 55

Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform

Chopra, G., & Samudrala, R. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160325121943 · Cited by 55

Non-coding genetic variation in cancer

Cuykendall, T. N., Rubin, M. A., & Khurana, E. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2016.12.017 · Cited by 55

Genomic characterisation of Eμ-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene

Lefebure, M., Tothill, R. W., Kruse, E., Hawkins, E. D., Shortt, J., Matthews, G. M., Gregory, G. P., Martin, B. P., Kelly, M. J., Todorovski, I., et al. (2017) · Nature Communications · doi:10.1038/ncomms14581 · Cited by 55

HER2 is not a cancer subtype but rather a pan-cancer event and is highly enriched in AR-driven breast tumors

Daemen, A., & Manning, G. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-0933-y · Cited by 56

Genomic analysis of benign prostatic hyperplasia implicates cellular relandscaping in disease pathogenesis

Middleton, L. W., Shen, Z., Varma, S., Pollack, A. S., Gong, X., Zhu, S., Zhu, C., Foley, J. W., Vennam, S., Sweeney, R. T., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.129749 · Cited by 55

The whole-genome panorama of cancer driversPreprint

Sabarinathan, R., Pich, O., Martincorena, I., Rubio-Pérez, C., Juul, M., Wala, J. A., Schumacher, S. E., Shapira, O., Sidiropoulos, N., Waszak, S. M., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/190330 · Cited by 55

Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer

Narayan, S., Bader, G. D., & Reimand, J. (2016) · Genome Medicine · doi:10.1186/s13073-016-0311-2 · Cited by 54

Network-Guided Analysis of Genes with Altered Somatic Copy Number and Gene Expression Reveals Pathways Commonly Perturbed in Metastatic Melanoma

Valsesia, A., Rimoldi, D., Martinet, D., Ibberson, M. R., Benaglio, P., Quadroni, M., Waridel, P., Gaillard, M., Pidoux, M., Rapin, B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018369 · Cited by 54

Systematic analyses of the cancer genome: lessons learned from sequencing most of the annotated human protein-coding genes

Sjöblom, T. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f31108 · Cited by 27

Abstract 2469: The COSMIC Cancer Gene Census - a comprehensive study of all mutated cancer-driving genes

Sońdka, Z., Speedy, H. E., Bamford, S., Cole, C. G., Ward, S. A., & Forbes, S. A. (2019) · Cancer Research · doi:10.1158/1538-7445.am2019-2469 · Cited by 1

Patterns of somatic mutation in human cancer genomes

Greenman, C. D., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G. R., Davies, H. R., Teague, J. W., Butler, A. P., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,143

Identification of cancer genes by mutational profiling of tumor genomes

Benvenuti, S., Arena, S., & Bardelli, A. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.02.015 · Cited by 26

[Genes associated to cancer].

Peralta-Rodríguez, R., Valdivia, A., Mendoza, M. C., de Rodríguez, J., Marrero–Rodríguez, D., Paniagua, L., Romero, P., Taniguchi, K., & Salcedo, M. (2015) · PubMed · Cited by 2